Acetoacetanilide (Cas 102-01-2) MSDS
Acetoacetanilide (Cas 102-01-2) MSDS
Acetoacetanilide (Cas 102-01-2) MSDS
acetoacetanilide
538329 Anonymous 102-01-2 Laboratory chemicals, Manufacture of substances
1.2 2. 2.1
Relevant identified uses of the substance or mixture and uses advised against
Identified uses
HAZARDS IDENTIFICATION Classification of the substance or mixture Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP]
Acute toxicity, Oral (Category 4) Acute toxicity, Dermal (Category 4)
2.2
Harmful in contact with skin and if swallowed. Wear suitable protective clothing.
2.3 3. 3.1
Acetoacetanilide
CAS-No. EC-No.
4. 4.1
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
4.2
4.3 5. 5.1
Further information
no data available
ACCIDENTAL RELEASE MEASURES Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure adequate ventilation. Avoid breathing dust.
6.2 6.3
Environmental precautions
Do not let product enter drains.
6.4 7. 7.1
EXPOSURE CONTROLS/PERSONAL PROTECTION Control parameters Components with workplace control parameters Exposure controls Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday.
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU).
9. 9.1
PHYSICAL AND CHEMICAL PROPERTIES Information on basic physical and chemical properties
a) Appearance b) Odour c) Odour Threshold Form: powder Colour: light yellow no data available no data available
d) pH no data available e) Melting point/freezing Melting point/range: 83 - 88 C - lit. point f) Initial boiling point and no data available boiling range g) Flash point 162,8 C - closed cup h) Evaporation rate no data available i) Flammability (solid, gas) no data available j) Upper/lower flammability or explosive limits k) Vapour pressure l) Vapour density m) Relative density n) Water solubility o) Partition coefficient: noctanol/water p) Autoignition temperature q) Decomposition temperature r) Viscosity s) Explosive properties t) Oxidizing properties no data available
no data available no data available no data available no data available no data available no data available no data available no data available no data available no data available
9.2
Acute toxicity
LD50 Oral - rat - 1.600 mg/kg LD50 Dermal - guinea pig - > 1.000 mg/kg LD50 Intraperitoneal - rat - 800 mg/kg Remarks: Behavioral:Somnolence (general depressed activity). Vascular:Regional or general arteriolar or venous dilation. Cyanosis LD50 Intraperitoneal - mouse - 300 mg/kg
Skin corrosion/irritation
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Aspiration hazard
no data available
Potential health effects Inhalation May be harmful if inhaled. May cause respiratory tract irritation. Ingestion Harmful if swallowed. Skin Harmful if absorbed through skin. May cause skin irritation. Eyes May cause eye irritation. Signs and Symptoms of Exposure
Absorption into the body leads to the formation of methemoglobin which in sufficient concentration causes cyanosis. Onset may be delayed 2 to 4 hours or longer.
Additional Information
RTECS: Not available
Contaminated packaging
15.
REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
16.